United States · FDA National Drug Code directory
Ethacrynic Acid
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50228-334_2a0ab1c4-a5f5-aeed-e063-6394a90a5992
- Product NDC
- 50228-334
- Form
- TABLET
- Composition / generic term
- Ethacrynic Acid
- Labeler
- ScieGen Pharmaceuticals Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190827
- Source listing expiry
- 20261231
Source-listed ingredients
- ETHACRYNIC ACID — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (50228-334-01) · 50228-334-01
- 100 TABLET in 1 BOTTLE (50228-334-10) · 50228-334-10
- 30 TABLET in 1 BOTTLE (50228-334-30) · 50228-334-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →